Best Practices for Postmarket Drug Safety Surveillance: FDA Seeks Comments

Best Practices for Postmarket Drug Safety Surveillance: FDA Seeks Comments

Submitted by admin on November 6, 2019 - 5:21pm
Source: 
RAPS.org
News Tags: 
FDA
post-marketing data
patient safety
Headline: 
Best Practices for Postmarket Drug Safety Surveillance: FDA Seeks Comments
snippet: 

The US Food and Drug Administration (FDA) on Wednesday released for public comment a draft version of best practices in drug and biologic postmarket safety surveillance.

Do Not Allow Advertisers to Use My Personal information